Christopher Reid is a Professor of Chemistry and Biochemistry in the Science and Technology Department, Bryant University in Smithfield, Rhode Island. He is a faculty fellow in the Center for Health and Behavioral Sciences at Bryant. He received his undergraduate with honors degree from Laurentian University in Sudbury Canada, an MSc from the University of Waterloo, and a PhD from the University of Guelph in Canada.
During Dr. Reid's training he developed a keen interest in chemical biology and microbial glycoscience with a focus on carbohydrate acting enzymes. As a post-doctoral fellow in Dr. Christine Szymanski's lab at the National Research Council (NRC), in Ottawa, he developed mass spectrometry-based methods for the analysis of lipid-linked oligosaccharides for bacterial N-glycosylation pathways. As an assistant research officer at the NRC in Dr. Susan Logan's group he investigated surface polysaccharides of C. difficile resulting in a patent for a potential vaccine candidate. In 2010, Dr. Reid joined the faculty of the Department of Science and Technology at Bryant University where he works in antimicrobial discovery and chemical biology with a focus on Gram-positive cell wall carbohydrate acting enzymes and peptidoglycan metabolism
